2013
DOI: 10.1111/cea.12186
|View full text |Cite
|
Sign up to set email alerts
|

Biochemical and immunological analysis of mould skin prick test solution: current status of standardization

Abstract: Commercially available mould SPT extracts showed high variability raising the question of comparability and reliability of SPT results. Possible consequences for diagnostic test outcome will be investigated in the next step.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
46
0
3

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 50 publications
(49 citation statements)
references
References 35 publications
0
46
0
3
Order By: Relevance
“…depth of puncture), status of skin reactivity, application devices , patients’ medication and others . In our previous study , a biochemical analysis of mould SPT solutions revealed both quantitative and qualitative differences depending not only on the mould species, but more specifically on the manufacturer. The questions arising from that analysis were the following: do these differences in extract composition also reveal differences in SPT results, and how good are the correlations/concordances between SPT from different manufacturers and the sIgE test?…”
Section: Introductionmentioning
confidence: 87%
“…depth of puncture), status of skin reactivity, application devices , patients’ medication and others . In our previous study , a biochemical analysis of mould SPT solutions revealed both quantitative and qualitative differences depending not only on the mould species, but more specifically on the manufacturer. The questions arising from that analysis were the following: do these differences in extract composition also reveal differences in SPT results, and how good are the correlations/concordances between SPT from different manufacturers and the sIgE test?…”
Section: Introductionmentioning
confidence: 87%
“…Previous studies have demonstrated significant variation in allergen content of commercial SPT extracts for birch and grass pollen, mould and occupational allergens . A large heterogenicity in in vivo and in vitro reactivity and allergen content among five commercial crustacean extracts was recently demonstrated .…”
Section: Introductionmentioning
confidence: 98%
“…Commercially available extracts may lack important allergens or may vary considerably in their allergen composition, leading to false-negative test results for certain patients. Varying allergen compositions and contents have been shown for skin prick test (SPT) solutions for the house dust mite Dermatophagoides pteronyssinus [29], the mould Alternaria alternata [30], and hazelnut [31] as well as for sublingual allergen immunotherapy products for house dust mite, storage mite, and birch pollen [32,33]. At least for routine diagnostics, a process called spiking (i.e., the addition of recombinant allergens) has been used to improve the quality of allergenic extracts such as latex [34], hazelnut [35], and wasp venom [36].…”
Section: Recombinant Allergens In Diagnostic Testsmentioning
confidence: 99%